Bladder Cancer

Muscle invasive bladder cancer presenting as recurrent autonomic dysreflexia - a wolf in wolf's clothing. June 24, 2018

Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies. June 22, 2018

Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer. June 22, 2018

FDA ALERT: RE: Label Updates in Clinical Trials for Some Patients Taking Pembrolizumab or Atezolizumab as Monotherapy to Treat Urothelial Cancer with Low Expression of PD-L1 June 22, 2018

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit from PD-1/PD-L1 Blockade in Advanced Urothelial Cancers June 21, 2018

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening. June 21, 2018

Hospitalization and Readmission Costs after Radical Cystectomy in a Nationally Representative Sample: Does Urinary Reconstruction Matter? June 21, 2018

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook. June 21, 2018

Low-Grade, Multiple, Ta Non-muscle-Invasive Bladder Tumors: Tumor Recurrence and Worsening Progression. June 21, 2018

MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer. June 20, 2018

Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy. June 20, 2018

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts. June 20, 2018

Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017. June 20, 2018

Bladder cancer recurrence surveillance by urine metabolomics analysis. June 19, 2018

The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance. June 19, 2018

Beyond classic risk adjustment: Socioeconomic status and hospital performance in urologic oncology surgery. June 18, 2018

Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer. June 18, 2018

Novel urinary biomarkers for the detection of bladder cancer: A systematic review. June 18, 2018

The Extent of Lymphadenectomy at the Time of Radical Cystectomy for Bladder Cancer and its Impact on Prognosis and Survival. June 15, 2018

[CT texture analysis in bladder carcinoma: histologic grade characterization]. June 15, 2018

Page 1 of 245